Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy

(MedPage Today) -- The investigational cell therapy deramiocel slowed upper limb functional decline in boys and young men with Duchenne muscular dystrophy, data from the phase III HOPE-3 trial showed. At 12 months, the mean percent change from...
Source
MedPage Today
Opens original article in a new tab



